|Bid||312.10 x 800|
|Ask||378.97 x 800|
|Day's range||308.50 - 324.36|
|52-week range||253.04 - 460.21|
|Beta (5Y monthly)||1.17|
|PE ratio (TTM)||40.26|
|Earnings date||16 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||443.73|
WILMINGTON, Mass., January 20, 2022--Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call
Charles River (CRL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
WILMINGTON, Mass. & BOSTON, January 19, 2022--Charles River and Valo Health announce a multiyear strategic partnership to provide clients with access to AI-enabled drug discovery.